TeaRx Xa Factor Direct Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TeaRx Xa Factor Direct Inhibitor, covering 2017-03-23 to 2017-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement [Phase 2]